Lyra Medical
- Company typePrivate
- Founded2011
- HeadquartersKerem Maharal, Israel
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lyra Medical does
Lyra Medical is a privately held, for-profit medical device company founded in 2011 and headquartered in Kerem Maharal, Israel. Per its stated short description, the company is focused on developing "a long-term solution for pelvic floor repair," placing it in the women's health / urogynecology surgical implant category that addresses pelvic organ prolapse and related reconstructive indications. The company is led by co-founder and CEO Iram Levit.
No specific products, underlying technology, proprietary features, regulatory clearances, patents, or clinical milestones are disclosed in the available source data. The publicly listed corporate website (http://www.lyramed.com/) renders only a loader/verification placeholder page and contains no About, Product, Pipeline, Investor, or Careers content, which materially limits visibility into the company's current technical and commercial posture.
No funding rounds, headcount, revenue, customer accounts, distribution agreements, certifications, or strategic partnerships are documented. As a result, the business model — including pricing mechanics, go-to-market approach, and customer segmentation (e.g., hospitals, specialty urogynecology practices, distributors) — cannot be characterized from the available evidence. The data profile is consistent with either a pre-commercial/clinical-stage entity that has not yet publicly disclosed substantive milestones, or a company operating at negligible public visibility.
Lyra Medical firmographics
Firmographics- Name
- Lyra Medical
- Website
- https://lyramed.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Ownership category
- akta.pro rank
Lyra Medical industry classification
Industry- Product category
- Women's Health Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine) (HLAKAJAE)
- akta.pro secondary industries
- Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)
Keywords
Where Lyra Medical is headquartered
LocationHeadquarters
- HQ city
- Kerem Maharal
- HQ country
- Israel
- HQ region
- Middle East
Markets served
Lyra Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Lyra Medical product offering
Product offeringCore offering
Lyra Medical develops and manufactures a medical device intended as a long-term solution for pelvic floor repair. The product is targeted at the surgical treatment of pelvic floor disorders in women, falling within the urogynecology and women's health medical device segment.
Differentiator
Problem solved
Functional benefit
Products and services
- Pelvic Floor Repair Device A surgical implant/device intended as a long-term solution for pelvic floor repair in women, used by surgeons and healthcare institutions for the treatment of pelvic floor disorders.
Companies that use Lyra Medical
Customer profileIdeal customer profiles1 record
Lyra Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Lyra Medical partnerships and signals
Strategic signalRecent moves1 record
Lyra Medical competitors and assessment
Company assessmentBroad incumbents
- Boston Scientific: Large diversified medtech with a significant urogynecology and pelvic floor repair portfolio (mesh, sling systems). Highly comparable as the dominant incumbent Lyra would need to displace in pelvic floor repair.
- CooperSurgical: Women's health-focused medical device company with surgical and pelvic health products — comparable as a women's health specialist acquirer-type peer active in the same procedural specialty.
- Cook Medical: Broad surgical-device manufacturer with pelvic floor and urogynecology offerings; comparable as another diversified incumbent competing in the same procedural specialty.
- Ethicon (Johnson & Johnson): Historically a major player in pelvic floor mesh via its Gynecare line (subsequently withdrawn amid litigation) — directly comparable product category and a bellwether for category regulatory dynamics.
Emerging players
- Cogentix Medical (now part of Laborie): Previously independent developer of minimally invasive pelvic floor products — comparable as a niche specialist that ultimately exited via acquisition, illustrating the strategic-acquisition pathway available to focused pelvic floor players.
- Axonics Modulation Technologies: Specialist in sacral neuromodulation for bladder and bowel dysfunction — adjacent pelvic floor therapeutic area, overlapping patient population and surgical call point, but a different modality (neuromodulation vs. surgical repair).
Direct peers
- Coloplast: Direct competitor in pelvic floor repair and women's health surgical devices, with established mesh and sling product lines serving urogynecologists — the most direct comparison to Lyra's stated focus.
- Caldera Medical: Specialist medical device company focused exclusively on pelvic floor repair and stress urinary incontinence implants — a near-pure-play peer and the closest comparability to Lyra Medical's single-product focus.
- Laborie Medical Technologies: Pelvic health medical device company offering diagnostics and surgical solutions for pelvic floor disorders — directly comparable category with overlapping urogynecology customer base.
Regional players
- Promedon: Argentina-based medical device company specializing in pelvic floor and urogynecology implants for Latin American and European markets — comparable product focus with regional rather than global commercial reach.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Lyra Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lyra Medical leadership team
Management profileNumber of profiles
Profiles1 record
Lyra Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lyra Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lyra Medical
What does Lyra Medical do?
Lyra Medical develops and manufactures a medical device intended as a long-term solution for pelvic floor repair. The product is targeted at the surgical treatment of pelvic floor disorders in women, falling within the urogynecology and women's health medical device segment.
Is Lyra Medical a public or private company?
Lyra Medical is a private company. It is classified as unknown and is currently operating.
When was Lyra Medical founded?
Lyra Medical was founded in 2011.
Where is Lyra Medical based?
Lyra Medical is headquartered in Kerem Maharal, Israel, in the Middle East region.
Who are Lyra Medical's main competitors?
Broad incumbents on record are Boston Scientific, CooperSurgical, Cook Medical and Ethicon (Johnson & Johnson). Emerging players are Cogentix Medical (now part of Laborie) and Axonics Modulation Technologies. Direct peers are Coloplast, Caldera Medical and Laborie Medical Technologies. Promedon is listed as a regional player.
Does Lyra Medical have an API?
No public API is recorded for Lyra Medical.
What industry is Lyra Medical in?
Lyra Medical's product category is Women's Health Medical Devices. Its primary akta.pro industry code is HLAKAJAE, Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine), with a secondary code of HLAKAOAC, Female Pelvic Medicine & Reconstructive Surgery (Urogynecology). Its NAICS code is 339112 and its SIC code is 3841.